Gene Editing

Edward Morello Excerpts
Tuesday 22nd July 2025

(4 days, 13 hours ago)

Westminster Hall
Read Full debate Read Hansard Text Read Debate Ministerial Extracts

Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.

Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.

This information is provided by Parallel Parliament and does not comprise part of the offical record

Steve Barclay Portrait Steve Barclay
- Hansard - - - Excerpts

The hon. Lady raises an important point. By embracing innovation in the technology, we can lead and, by leading, show the benefits to farming and nature that the EU may wish to follow. The EU regulation is cumbersome. It brings gene editing within the fold of gene modification. The pace of change is slow and its scope more limited. It is better to move ahead and show the benefits, rather than wait for the back-marker to see if they eventually come to the table and make the changes, many years after elsewhere in the world has moved on. The hon. Lady is right to highlight the pace of regulatory change and the sluggish nature of the EU.

The opportunity of this technology is not far away. I mentioned a moment ago the grants that we had awarded for research into virus yellows disease. Researchers hope to have plants by the end of this decade that, if successful, will do away with the need for the harmful treatments and the dilemma that Ministers face as to whether to grant emergency authorisation. That would protect British sugar beet farmers from potentially catastrophic losses, while also increasing crop productivity and resilience, and at the same time increase sustainability and bring direct benefits to nature. I have long believed that there is an opportunity to see farming and nature not as opposites, but as complementary, and we can boost farming in ways that also are beneficial to nature.

The hon. Member for Cannock Chase (Josh Newbury) talked about the public response, and he is right to do so. I am pleased to note that the public at large support gene editing because of its environmental and economic benefits. A recent study found support among the public at 70% across the population as a whole. Interestingly, that rose to 80% among generation Z, so there is widespread support among the public. But if we are to realise the benefits and capitalise on that public support, we need to get the regulation right.

That brings me, as the hon. Member for Upper Bann (Carla Lockhart) mentioned a moment ago, to European regulation. Back in 2018, the European Court of Justice ruled that gene-edited crops are subject to the same 2001 legislation as gene-modified organisms. Yet, as we touched on, the two techniques are very different and should not be confused. Gene editing speeds up changes that could occur naturally or through conventional selective breeding; it is unlike gene modification, which is where DNA from different species has been introduced to another, creating new types of plants and animals that could not have come about through natural methods. As a result, gene editing is a much lower and different risk, and should be treated in regulation differently from gene modification, but that is not the position of the European Union.

Even the European Commission has realised that its regulatory approach is not fit for purpose, but progress is remarkably slow in changing it. While it is working on its own legislation, it will come years later and be more limited in scope than what we have done in the United Kingdom. After Brexit, the UK was able to diverge, which is why the previous Conservative Government brought forward the Genetic Technology (Precision Breeding) Act 2023, which removed precision-bred plants and animals from the existing genetically modified organism regulatory system. The Act created a new framework for their oversight and provided the Secretary of State with powers of secondary legislation.

I commend the Government and the Minister on pressing ahead with the required secondary legislation to bring this new system in for plants, which is due to come into force in November. So why the need for this debate? This debate is needed because I fear that the current optimism is a high point in this journey and that we are about to see the UK surrender the advantage that will help our farmers and our nature, and that has been gained with the primary and secondary legislation in place. To prevent that, I am seeking assurances from the Minister in three key areas: implementation, further expansion, and funding.

First, on implementation, the Prime Minister’s EU reset at the UK-EU summit included plans for sanitary and phytosanitary agreement. To achieve that, the EU has suggested that dynamic alignment will be required of the UK, meaning that all relevant EU rules will apply to UK goods. As a result, some experts have suggested that there would need to be a pause on the UK’s progress in taking forward more effective regulation of gene editing, and that we would need to then wait while the EU spends potentially years putting in place its own more limited reforms.

Waiting would hold back centres such as the John Innes Centre, UK science and development, and give up our hard-won commercial competitive advantage in terms of the sector and the jobs it employs. I mentioned how important gene editing crops will be to areas such as my constituency, and to leading businesses such as British Sugar, which works with over 3,500 growers and is concerned about alignment on this matter. It would urge the Government not to sacrifice the UK bioscience sector’s progress on gene editing in the UK-EU trade negotiations and to recognise that delaying the use of the technology in the UK would put us at risk of falling behind other countries using it. I wholeheartedly agree with that analysis and assessment. Will the Minister confirm that the Genetic Technology (Precision Breeding) Regulations 2025 will come into force in November this year, and that there will be no delay?

Secondly, on further expansion, I note that only regulations on gene editing plants have been brought forward. It was always the intention that plants would be first, and that regulations relating to animals would come second. This will provide another opportunity compared with the European Union. Discussions at an EU level suggest that animals will be excluded from its regulations, whenever they eventually emerge. It is vital that we capitalise on that opportunity, too. Will the Minister confirm that it is still the Government’s intention to bring forward the required secondary legislation under the Genetic Technology (Precision Breeding) Regulations 2023 to remove precision-bred animals for the existing genetically modified organism regulatory system?

Finally, on funding, I know the challenge that Department for Environment, Food and Rural Affairs Ministers will be facing when it comes to negotiations with the Treasury, having been within both DEFRA and the Treasury, and given that farming is seemingly not a priority for the Labour Government, with £100 million of cuts to farming and countryside programmes announced in the spending review. Given that spending backdrop, one might have thought the Minister would want to maximise opportunities to boost farming and nature, which do not come at a cost to the Treasury.

Edward Morello Portrait Edward Morello (West Dorset) (LD)
- Hansard - -

The right hon. Member raises a very important point: the Government may be cutting funding for farming, but they are very much pursuing climate change goals. Farming is facing periods of extreme weather—we have just had some of the driest and wettest months on record. One of the great successes of gene editing was dwarf wheat, which was drought resistant and allowed places such as Mexico and India to become net exporters of food. Would pursuing gene editing for British farmers not offer them protection against climate change and therefore protection against cuts to the farming budget?

Steve Barclay Portrait Steve Barclay
- Hansard - - - Excerpts

The hon. Gentleman is absolutely right, and that builds on the earlier intervention on public support. One of the sweet spots of this area of policy is that it is beneficial to farming—because it cuts costs on things like pesticides and increases yield—but it is also hugely beneficial to nature, in terms of climate change. It is also beneficial for the public purse, because gene editing is a way of using science, in essence, to drive productivity and nature-beneficial schemes, rather than simply spending public money.

For context, I am sure the Minister will have seen the farming figures this morning. The Government borrowed £20.7 billion in June alone—the highest figure since records began, with the exception of June 2020, during peak covid. That is not an isolated figure. If we look at the previous month, the Government borrowed £17.7 billion in May. That was also the highest on record for May—again, with the exception of May 2020. So the Government are borrowing record sums, and the Department’s budget is under pressure—all the more reason not to sacrifice genuine scientific opportunities, particularly those that, as we have explored, have widespread public support.

Will the Minister recognise that gene editing jointly serves the goals of food production and protecting nature, and ensure that we do not give away our competitive advantage? Specifically, will he confirm that the £12.5 million from the recent farming futures research and development fund for the precision breeding competition—aimed at mid-stage precision breeding projects—will be paid in full? Will he also confirm that funding will be made available directly to farmers to take part in field trials, so that the science actually progresses?

In conclusion, gene editing is a genuine Brexit opportunity. It can boost economic growth, support food production, help protect our environment, and give us a competitive advantage over other countries. To sacrifice that as part of some UK-EU reset negotiations would be a serious mistake. It would be another example in a long list of decisions where the Department has been overridden by the Treasury.

There is still time. The legislation is in place; the regulations are there. Can the Minister confirm today that gene editing will continue to be a priority, and that the UK Government will secure the advantages that it offers?